Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference
-
Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease
-
ProMOS Adopts Silvaco Victory TCAD Solution for the Development of Next-Gen Silicon Photonics Devices
-
Man Group PLC : Form 8.3 - Dalata Hotel Group plc
-
AGF Investments Announces Additional Ad Hoc Distributions for AGF Systematic Global Multi-Sector Bond ETF, AGF Systematic International Equity ETF and AGF Systematic US Equity ETF
-
Defiance Launches $GLDY, Gold Enhanced Options Income ETF
-
SFL - Notice of Annual General Meeting 2025
-
Fixing of coupon rates - Nykredit Realkredit A/S
-
Marex Group plc provides preliminary Q1 results range and hosts Investor Day in New York
-
Lack of Employment Services Exacerbates Economic Disparities for English Speakers in Montréal
-
Cartesian Therapeutics Announces New Employment Inducement Grants
-
Syntiant to Unveil Vision Transformer Security Solution at ISC West 2025
-
SchoolAI Secures $25 Million to Help Teachers and Schools Reach Every Student
-
Building on Past Success, Incident IQ Names Ryan Zeek as Chief Financial Officer
-
Green Thumb Industries to Hold First Quarter 2025 Earnings Conference Call on May 7, 2025
-
The NHL and Rogers Announce Monumental 12-Year National Media Rights Deal
-
Prospect’s Real Estate Private Credit Platform Provides $10.9 Million to Class A Stabilized Cash Flowing Multifamily Property in Brooklyn
-
Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors
-
Anfield Appoints Ross McElroy to Board of Directors and Announces Results of Special Shareholder Meeting
-
Nurix Licenses a Drug Discovery Program to Sanofi Targeting a Novel Transcription Factor for Autoimmune Diseases
-
Plantro Ltd. Announces Premium All-Cash Tender Offer to Acquire up to 15% of Class A Limited Voting Shares of Information Services Corporation
-
Global Helium Corp. Announces Sale of Standing Well and Lands in Montana
-
Norwegian Cruise Line Holdings Ltd. and NCL Corporation Ltd. Announce Exchangeable Notes Refinancing Transaction
-
Gainsight Acquires Skilljar, Enabling Learning Everywhere
-
Investigators to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PD™ 2025
-
Lantronix Named to CRN 2025 Internet of Things 50 List
-
Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference
-
RYVYL EU Payments-as-a-Service Contracts Rapidly Onboarding New Accounts
-
SANTO TOMAS PROJECT MOVES FORWARD
-
Organizations accelerating AI investments—early results are underwhelming: Survey report says
-
Bitfarms Enters into Initial Agreement for Private Debt Facility with a division of Macquarie Group for up to $300 Million to Fund Initial HPC Project Development at Panther Creek
-
Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference
-
Nayax Announces Acquisition of Inepro Pay
-
Winnebago Industries Announces Settlement of 2025 Convertible Senior Notes
-
Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting
-
Prairie Operating Co. Announces 11-Well Development at Rusch Pad
-
Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
-
Mekanism Merges with Camp Jefferson and Jungle to Form Mekanism Canada
-
Tilray Shifts Cultivation of its Flagship Canadian Cannabis Brand and Strain, Good Supply Jean Guy, to Masson-Angers Facility in Québec
-
Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum
-
Employee Trust Fuels Financial Success at the 100 Best Companies to Work For in 2025
-
CMR Surgical secures more than $200M to accelerate growth
-
Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment
-
Manitoba’s construction sector to see healthy growth in residential and non-residential activity to 2034
-
Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference
-
YieldMax™ ETFs Announces Distributions on FIAT (127.21%), CVNY (100.49%), ULTY (77.62%), CONY (73.33%), YMAX (68.44%) and Others
-
Form 8.3 - AXA INVESTMENT MANAGERS: Aviva plc
-
Parsons Selected for PFAS Investigation and Remedy Development at Tucson International Airport
-
Kraken Robotics Completes Acquisition of 3D at Depth
-
Multiple Pay Zones Discovered in Successful Drill Program
